Aligos Therapeutics Inc (NASDAQ:ALGS) currently has a daily average trading volume of 266.34K but it saw 276824 shares traded in last market. With a market cap of 82.48M USD, the company’s current market price of $22.99 came rising about 7.68 while comparing to the previous closing price of $21.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $30.00 and as low as $6.76. In the recent trading on the day, stock has struck highest price mark of $21.51 while lowest mark touched by it was $23.7.
Taking a look at 20-day trading activity of Aligos Therapeutics Inc (ALGS) gives us an average price of $15.98, while its current price level is -23.37% below from 52-week high level whereas it is 240.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $11.25 while that of 200 days or SMA-200 reads an average of $15.43. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.47% during that period while stretching the period over a month that increases to 19.36%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 81.13 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on August 19, 2024, recommending a price target of $75 for it. Piper Sandler upgraded its recommendation for the stock as a “Overweight” from “Neutral” on January 06, 2023 while assigning a price target range of $2-$3. Jefferies issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $2.50 and $3.
Over the week, ALGS’s stock price is moving 26.32% up while it is 145.62% when we observe its performance for the past one month. Year-to-date it is 38.49% up and over the past year, the stock is showing an upside performance of 31.37%.
Currently, Aligos Therapeutics Inc’s total number of outstanding shares is 2.88M. Company’s return on investment (ROI) stands at -137.84% and return on equity (ROE) at -146.69%. Stock’s beta reads 2.55. Stock has a price to book (P/B) ratio of 1.53 while price to sale or P/S ratio amounts to 13.75. Its return on asset (ROA) is -88.31% on average.
